Recovered COVID-19 patients exceed active cases by over 1 lakh: Health Ministry

A total of 3,09,712 patients have been cured of COVID-19 so far with 13,832 patients having recovered in the last 24 hours, it said.

PTI

June 28, 2020 / 15:01 IST

The gap between recoveries and active cases of COVID-19 has crossed 1,00,000, the Union health ministry said on June 28 as coronavirus cases in India mounted to 5,28,859 and the death toll rose to 16,095. The recovered cases have exceeded the active cases by 1,06,661 as on June 27, the ministry said.

A total of 3,09,712 patients have been cured of COVID-19 so far with 13,832 patients having recovered in the last 24 hours, it said.

"The recovery rate is 58.56 percent amongst COVID-19 patients," the ministry said.

"The graded, pre-emptive and pro-active steps taken by the Government of India along with the states and UTs for prevention, containment and management of COVID-19 are showing encouraging results," it said in a statement.

Presently, there are 2,03,051 active cases and all are under active medical supervision, it said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show